Eitan Medical UK Limited Filleted Accounts Cover
Eitan Medical UK Limited
Audited accounts
Company No. 12738832
Information for Filing with The Registrar
31 December 2024
Eitan Medical UK Limited Directors Report Registrar
The Directors present their report and the accounts for the year ended 31 December 2024.
Principal activities
The principal activity of the company during the year under review was selling and marketing of medical supplies.
Directors
The Directors who served at any time during the year were as follows:
S. Eitan
(Appointed on 27 June 2024)
G.Y. Hadar
I. Shany
(Resigned 1 January 2024)
S. Sharoni
(Resigned 27 June 2024)
Auditors
The auditors, Gordon Levy Limited, will be proposed for appointment in accordance with Section 486 of the Companies Act 2006.
The above report has been prepared in accordance with the provisions applicable to companies subject to the small companies regime as set out in Part 15 of the Companies Act 2006.
Signed on behalf of the board
G.Y. Hadar
Director
04 September 2025
Eitan Medical UK Limited Balance Sheet Registrar
at
31 December 2024
Company No.
12738832
Notes
2024
2023
£
£
Fixed assets
Tangible assets
4
1,458175
1,458175
Current assets
Stocks
5
1,037,313744,240
Debtors
6
1,159,138447,341
Cash at bank and in hand
517,447311,857
2,713,8981,503,438
Creditors: Amount falling due within one year
7
(2,949,366)
(1,923,671)
Net current liabilities
(235,468)
(420,233)
Total assets less current liabilities
(234,010)
(420,058)
Net liabilities
(234,010)
(420,058)
Capital and reserves
Called up share capital
11
Profit and loss account
8
(234,011)
(420,059)
Total equity
(234,010)
(420,058)
These accounts have been prepared in accordance with the special provisions applicable to companies subject to the small companies regime of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
As permitted by section 444 (5A)of the Companies Act 2006 the directors have not delivered to the Registrar a copy of the company's profit and loss account.
Approved by the board on 04 September 2025 and signed on its behalf by:
G.Y. Hadar
Director
04 September 2025
Eitan Medical UK Limited Notes to the Accounts Registrar
for the year ended 31 December 2024
1
General information
Eitan Medical UK Limited is a private company limited by shares and incorporated in England and Wales.
The company's registered number is: 12738832
The address of the company's registered office is:
201 Haverstock Hill
Second Floor
London
England
NW3 4QG
The accounts have been prepared in accordance with FRS 102 Section 1A - The Financial Reporting Standard applicable in the UK and Republic of Ireland (January 2022) and the Companies Act 2006.
2
Accounting policies
Turnover
Turnover is measured at the fair value of the consideration received or receivable. Turnover is reduced for estimated customer returns, rebates and other similar allowances.

Revenue from the sale of goods is recognised when all the following conditions are satisfied:
• the Company has transferred to the buyer the significant risks and rewards of ownership of the
goods;
• the Company retains neither continuing managerial involvement to the degree usually associated
with ownership nor effective control over the goods sold;
• the amount of revenue can be measured reliably;
• it is probable that the economic benefits associated with the transaction will flow to the Company;
and
• the costs incurred or to be incurred in respect of the transaction can be measured reliably.

Specifically, revenue from the sale of goods is recognised when goods are delivered and legal title is passed.
Tangible fixed assets and depreciation
Tangible fixed assets held for the company's own use are stated at cost less accumulated depreciation and accumulated impairment losses.

At each balance sheet date, the company reviews the carrying amount of its tangible fixed assets to determine whether there is any indication that any items have suffered an impairment loss. If any such indication exists, the recoverable amount of an asset is estimated in order to determine the extent of the impairment loss.
Depreciation is provided at the following annual rates in order to write off the cost or valuation less the estimated residual value of each asset over its estimated useful life:
Furniture, fittings and equipment
33% Straight line
Taxation
Income tax expense represents the sum of the tax currently payable and deferred tax.

The tax currently payable is based on taxable profit for the year. Taxable profit differs from profit as reported in the profit and loss account because of items of income or expense that are taxable or deductible in other years and items that are never taxable or deductible. The Company's liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the end of the reporting period.

Deferred tax is recognised on timing differences between the carrying amounts of assets and liabilities in the financial statements and the corresponding tax bases used in the computation of taxable profit. Deferred tax liabilities are generally recognised for all taxable temporary differences. Deferred tax assets are generally recognised for all deductible timing differences to the extent that it is probable that taxable profits will be available against which those deductible temporary differences can be utilised. The carrying amount of deferred tax assets is reviewed at the end of each reporting period and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered.

Deferred tax assets and liabilities are measured at the tax rates that are expected to apply in the period in which the liability is settled or the asset realised, based on tax rates (and tax laws) that have been enacted or substantively enacted by the end of the reporting period.

Current or deferred tax for the year is recognised in profit or loss, except when they relate to items that are recognised in other comprehensive income or directly in equity, in which case, the current and deferred tax is also recognised in other comprehensive income or directly in equity respectively.
Stocks
Stocks are stated at the lower of cost and net realisable value. Net realisable value is based upon estimated selling prices less further costs expected to be incurred to disposal.
At each balance sheet date, stocks are assessed for impairment. If stock is impaired, the carrying amount is reduced to its selling price less costs to complete and sell. The impairment loss is recognised immediately in the statement of comprehensive income.
Work in progress is reflected in the accounts on a contract by contract basis by recording revenue and related costs as contract activity progresses.
Trade and other debtors
Trade and other debtors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest method, less impairment losses for bad and doubtful debts.
Trade and other creditors
Short term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.
Foreign currencies
The functional and presentational currency of the company is Sterling. The accounts are rounded to the nearest pound.
Transactions in currencies, other than the functional currency of the Company, are recorded at the rate of exchange on the date the transaction occurred. Monetary items denominated in other currencies are translated at the rate prevailing at the end of the reporting period. all differences are taken to the profit and loss account. Non-monetary items that are measured at historic cost in a foreign currency are not retranslated.
Judgements and key sources of estimation uncertainty
The preparation of the financial statements requires management to make judgements, estimates and assumptions that affect the amounts reported. These estimates and judgements are continually reviewed and are based on experience and other factors including expectations of future events that are believed to be reasonable under the circumstances.
Financial instruments
The company only enters into basic financial instruments transactions that result in the recognition of financial assets and liabilities like trade and other accounts receivable and payable.
Cash and cash equivalents
Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.
Operating leases: as lessee
Rentals paid under operating leases are charged to profit or loss on a straight-line basis over the lease
term. Benefits received and receivable as an incentive to sign an operating lease are recognised on a
straight-line basis over the lease term, unless another systematic basis is representative of the time
pattern of the lessee's benefit from the use of the leased asset.
Financial assets
Financial assets that are measured at cost and amortised cost are assessed at the end of each reporting period for objective evidence of impairment. If objective evidence of impairment is identified, an impairment loss is recognised in profit or loss.
For financial assets measured at amortised cost, the impairment loss is measured as the difference between an asset's carrying amount and the present value of estimated cash flows discounted at the asset's original effective interest rate.
For financial assets measured at cost less impairment, the impairment loss is measured as the difference between an asset's carrying amount and its recoverable amount, which is an estimate of the amount that the company would receive for the asset if it were to be sold at the reporting date.
Defined contribution pensions
The Company operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the company pays fixed contributions into a separate entity. Once the contributions have been paid the company has no further payments obligations.
The contributions are recognised as expenses when they fall due. Amounts not paid are shown in accruals in the balance sheet. The assets of the plan are held separately from the company in independently administered funds.
Going concern
These financial statements have been prepared on a going concern basis. The director, having considered the financial position of the company for a period of at least twelve months from the date of signing these financial statements, has no reason to believe that a material uncertainty exists that may cast doubt about the ability of the company to continue as a going concern. Accordingly the director has a reasonable expectation that the company will continue in operational existence and therefore he continues to adopt the going concern basis of accounting to prepare the financial statements.
3
Employees
2024
2023
Number
Number
The average monthly number of employees (including directors) during the year was:
95
4
Tangible fixed assets
Fixtures, fittings and equipment
Total
£
£
Cost or revaluation
At 1 January 2024
5,9065,906
Additions
2,0592,059
At 31 December 2024
7,9657,965
Depreciation
At 1 January 2024
5,7315,731
Charge for the year
776776
At 31 December 2024
6,5076,507
Net book values
At 31 December 2024
1,4581,458
At 31 December 2023
175
175
5
Stocks
2024
2023
£
£
Finished goods
1,037,313744,240
1,037,313744,240
6
Debtors
2024
2023
£
£
Trade debtors
1,077,716434,152
Deferred tax asset
78,133-
Other debtors
2,5202,378
Prepayments and accrued income
76910,811
1,159,138447,341
7
Creditors:
amounts falling due within one year
2024
2023
£
£
Trade creditors
3,47623,067
Taxes and social security
253,727
105,343
Other creditors
2,619,1941,595,377
Accruals and deferred income
72,969199,884
2,949,3661,923,671
8
Reserves
Profit and loss account - includes all current and prior period retained profits and losses.
9
Guarantees and commitments
2024
2023
£
£
Total of guarantees and commitments
4,5454,370
10
Related party disclosures
Transactions with related parties
The company has taken advantage of the exemption available according to FRS 102 1A "Related party
disclosure" not to disclose transactions entered into between two or more members of a group that are
wholly owned.
Ultimate controlling party
The ultimate parent undertaking is Eitan Medical Ltd, a company incorporated in Israel, whose principal place of business is 29 Yad Haruzim St. PO Box 8639, Netanya, 4250529, Israel.
Parent Company
The name of the parent of the smallest group for which consolidated financial statements are drawn up of which this entity is a member:
Eitan Medical Ltd
The parent's registered office address is:
29 Yad Haruzim St.
P.O. Box 8639
Netanya
4250529 Israel
11
Audit of the accounts
Unqualified
The auditors were: Gordon Levy Limited
Gordon Levy Limited
The senior statutory auditor was: Gordon Levy BA, FCA
Eitan Medical UK Limited1273883231 December 202401 January 2024false04 September 2025BTCSoftware AP Solution 2025 12.1.0312.1.03These accounts have been prepared in accordance with the special provisions applicable to companies subject to the small companies regime of the Companies Act 2006.For the year ended 31 December 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.true127388322024-01-012024-12-31127388322024-12-31127388322023-12-3112738832core:WithinOneYear2024-12-3112738832core:WithinOneYear2023-12-3112738832core:ShareCapital2024-12-3112738832core:ShareCapital2023-12-3112738832core:RetainedEarningsAccumulatedLosses2024-12-3112738832core:RetainedEarningsAccumulatedLosses2023-12-3112738832countries:UnitedKingdom2024-01-012024-12-3112738832bus:RegisteredOffice2024-01-012024-12-3112738832core:FurnitureFittingsToolsEquipment2024-01-012024-12-31127388322023-01-012023-12-3112738832core:FurnitureFittingsToolsEquipment2024-01-01127388322024-01-0112738832core:FurnitureFittingsToolsEquipment2024-12-3112738832core:RetainedEarningsAccumulatedLosses2024-01-012024-12-3112738832bus:SmallEntities2024-01-012024-12-3112738832bus:FullAccounts2024-01-012024-12-3112738832bus:AuditExempt-NoAccountantsReport2024-01-012024-12-3112738832bus:Director22024-01-012024-12-3112738832bus:PrivateLimitedCompanyLtd2024-01-012024-12-31iso4217:GBPxbrli:pure